SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001628280-24-020453
Filing Date
2024-05-06
Accepted
2024-05-06 07:03:15
Documents
5
Effectiveness Date
2024-05-06

Document Format Files

Seq Description Document Type Size
1 S-8 s-82024evergreensharesmay2.htm S-8 58514
2 EX-FILING FEES ex1071s-8filingfeetablemay.htm EX-FILING FEES 19657
3 EX-5.1 ex51opinionrgs-8.htm EX-5.1 10373
4 EX-23.1 ex231deloitte-formsx8conse.htm EX-23.1 2110
5 GRAPHIC image_0.jpg GRAPHIC 2164
  Complete submission text file 0001628280-24-020453.txt   94831
Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Filer) CIK: 0001822462 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-279128 | Film No.: 24915510
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)